Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study
- PMID: 29454319
- PMCID: PMC5816553
- DOI: 10.1186/s12885-018-4118-y
Treatment of upper tract urothelial carcinoma with ureteroscopy and thulium laser: a retrospective single center study
Abstract
Background: Treatment with the combination of ureteroscopy and thulium laser ablation may provide an alternative to radical nephroureterectomy (RNU) for patients with upper tract urothelial carcinoma (UTUC). The purpose of this study was to investigate the efficacy and safety of this technique.
Methods: We performed a retrospective review of the data for patients who were treated surgically for upper tract urothelial carcinoma in a single center. It included 32 patients treated by endoscopic thulium laser resection and 107 patients treated by radical nephroureterectomy (RNU). We compared the data of patient sex, age at diagnosis, location of carcinoma, length of hospitalization, tumor site, size, grade, recurrence, preoperative creatinine and postoperative creatinine in two groups. Patients were examined by ureteroscopy every 3 months during the first year after surgery, then every 6 months each year.
Results: All 32 patients were treated successfully, among which 6 were operated by a flexible ureteroscope. The average tumor size was 13 ± 7 mm in diameter. The tumor was rated as low grade in 27 patients and high grade in 5 patients. Ureteral stricture developed in 4 patients 3 months later after surgery, but the stricture was succesfully treated through endoscopic dilation. Seven patients had tumor recurrence, 3 of which underwent nephroureterectomy during the follow-up. Postoperative creatinine levels (umol/L) were respectively 89 ± 7.5 in laser group and 123 ± 15.4 in RNU group (p < 0.01). Length of hospitalization was respectively 3.6 ± 1.9 and 8.6 ± 2.4 days (p < 0.01). Local or bladder recurrence rate of thulium laser group and RNU group was respectively 21.9 and 13.1% (p < 0.01).
Conclusions: Thulium laser group is associated with a less loss of renal function, a shorter length of hospitalization, but a higher rate of tumor recurrence. Thulium laser therapy combined with ureteroscopic treatment can be considered as an acceptable treatment for selected cases of UTUC. Lifetime intensive surveillance is necessary.
Keywords: Laser therapy; Upper tract; Ureteroscopic treatment; Urothelial carcinoma.
Conflict of interest statement
Ethics approval and consent to participate
This study was approved by the ethics committee of Peking Union Medical College Hospital and written informed consent from each of the patients were acquired.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Thulium-laser retrograde intra renal ablation of upper urinary tract transitional cell carcinoma: an ESUT Study.Minerva Urol Nephrol. 2021 Feb;73(1):114-121. doi: 10.23736/S2724-6051.20.03689-9. Epub 2020 Jan 30. Minerva Urol Nephrol. 2021. PMID: 32026668
-
Thulium-Holmium:YAG Duo Laser in Conservative Upper Tract Urothelial Cancer Treatment: 13 Years Experience from a Tertiary National Referral Center.J Endourol. 2019 Nov;33(11):902-908. doi: 10.1089/end.2019.0308. Epub 2019 Sep 25. J Endourol. 2019. PMID: 31422699
-
Immediate Nephroureterectomy or After Attempting Conservative Treatment, on Elective Indications, for Upper Urinary Tract Urothelial Carcinoma: Comparison of the Pathology Reports on a Retrospective Monocentric Study.J Endourol. 2015 Aug;29(8):969-73. doi: 10.1089/end.2015.0044. Epub 2015 Jun 18. J Endourol. 2015. PMID: 25873006
-
[Transurethral flexible ureteroscopic holmium laser resection for tumors of renal pelvis: 6 cases report and literature review].Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Oct 18;50(5):816-821. Beijing Da Xue Xue Bao Yi Xue Ban. 2018. PMID: 30337741 Review. Chinese.
-
Endoscopic Treatment of Upper Tract Urothelial Carcinoma.Curr Urol Rep. 2017 Apr;18(4):31. doi: 10.1007/s11934-017-0675-x. Curr Urol Rep. 2017. PMID: 28251485 Review.
Cited by
-
A Systematic Review of Thulium Fiber Laser: Applications and Advantages of Laser Technology in the Field of Urology.Res Rep Urol. 2021 Jul 22;13:519-527. doi: 10.2147/RRU.S233979. eCollection 2021. Res Rep Urol. 2021. PMID: 34327179 Free PMC article. Review.
-
Effectiveness and Safety of Thulium Fiber Laser in the Conservative Management of Patients with Upper Tract Urothelial Carcinoma.Eur Urol Open Sci. 2022 Nov 10;46:99-104. doi: 10.1016/j.euros.2022.10.010. eCollection 2022 Dec. Eur Urol Open Sci. 2022. PMID: 36506254 Free PMC article.
-
Endoscopic Ablation of Upper Tract Urothelial Carcinoma: A Report of Two Cases with Long Disease Recurrence-Free Periods.Yonago Acta Med. 2022 Apr 23;65(2):171-175. doi: 10.33160/yam.2022.05.005. eCollection 2022 May. Yonago Acta Med. 2022. PMID: 35611056 Free PMC article.
-
Experts' recommendations in laser use for the treatment of upper tract urothelial carcinoma: a comprehensive guide by the European Section of Uro-Technology (ESUT) and Training Research in Urological Surgery and Technology (T.R.U.S.T.) group.World J Urol. 2023 Nov;41(11):3367-3376. doi: 10.1007/s00345-023-04632-4. Epub 2023 Oct 1. World J Urol. 2023. PMID: 37777981
-
Role of lasers in urology.Photochem Photobiol Sci. 2019 Feb 13;18(2):295-303. doi: 10.1039/c8pp00409a. Photochem Photobiol Sci. 2019. PMID: 30640321 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources